WSJ Tech News Briefing
How AI Is Cracking the Case on Medical Mysteries
· Summarized
Key takeaways
- AI is significantly impacting the book publishing industry, with an increasing prevalence of AI-generated 'Slop books' that challenge traditional notions of authorship and authenticity.
- Major publishers are cautious about fully banning AI use, but initiatives like the authors' guild human certification aim to promote transparency.
- In healthcare, AI shows promise in diagnosing rare diseases faster and more accurately than humans in some cases, especially through pattern recognition and facial analysis.
- Despite its potential, AI tools can hallucinate (produce false information), and privacy concerns are critical when sharing sensitive health data—regulations and safeguards are essential to prevent misuse.
Summary
AI's Impact on the Book Publishing Industry
This section discusses the evolving role of AI in book publishing, focusing on the phenomenon of 'Slop books'—books largely generated by language models that often contain false or plagiarized material designed to deceive buyers. It highlights the challenges publishers, agents, and authors face in verifying AI involvement, with many agents reporting an increase in spam and AI-generated manuscripts. The conversation covers how major publishers are hesitant to fully restrict AI use, preferring to wait and see how norms develop. Additionally, the authors' guild has introduced a human-authored certification to promote transparency, although its adoption remains limited amidst concerns about enforcement and reputation.
AI in Medical Diagnostics for Rare Diseases
This section explores how AI is revolutionizing diagnosis of rare and elusive medical conditions. Through stories like Rachel Hinken’s, who used facial recognition AI to identify a rare genetic disorder in her son, the segment illustrates AI's capacity for pattern matching—analyzing physical features, scans, and medical literature to suggest diagnoses. Studies showing AI outperforming human doctors in diagnosing complex cases are discussed, emphasizing AI’s potential to assist clinicians, especially when dealing with rare diseases that are often missed or misdiagnosed. The segment also addresses limitations like 'hallucinations' (incorrect AI outputs) and privacy concerns regarding personal medical data, underscoring the need for careful application and regulation.
Sponsors
- Simplecast, an AdsWizz company · See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Show notes
Patients, doctors and nurses are turning to AI for help identifying rare and undiagnosed diseases. WSJ reporter Alex Janin explains what makes AI good at playing medical detective, and how some people have used it effectively. Plus, the book publishing industry is in chaos, and AI is to blame. Journal reporter Anna Silman discusses the reckoning that authors, publishers and agents are facing over the use of AI in book writing. Belle Lin, a reporter for The Wall Street Journal Leadership Institute, hosts.
Sign up for the WSJ's free Technology newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Follow this show on AudioBrevity and new episodes get summarized for you. Create a free account